Nevirapine
Composition
The formulation Contains nevirapine as the active ingredient.
Indications
HIV infection
Side effects
Rash, liver toxicity
Precautions
Monitor liver function tests, rash
Contraindications
Severe liver disease, previous nevirapine-associated rash
Dosage and administration
Initial dose gradually increased to full dose to reduce risk of rash
Countries
South Africa, India
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai